PEG-Based Bispecific ADC: Better Tumor Penetration, Wider Therapeutic Window
Time: 4:00 pm
day: Day Two
Details:
- Assessing how it provides better tumor penetration
- Discussing how there were not any Fc related toxicities
- Exploring how it has a wider therapeutic window
